PharmaCorp RxTSXV:PCRX +1.96%36 Net Margin % is 1.50% as of Mar. 2026. GuruFocus rates TSXV:PCRX with a GF Score™ of 36/100. The stock has 2 warning signs investors should review. Among 668 Healthcare Providers & Services companies, PharmaCorp Rx ranks worse than 72.75% on this metric.
Net margin is calculated as Net Income divided by its Revenue. PharmaCorp Rx's Net Income for the
three
months ended in Mar. 2026 was C$0.11 Mil. PharmaCorp Rx's Revenue for the
three
months ended in Mar. 2026 was C$7.19 Mil. Therefore, PharmaCorp Rx's net margin for the quarter that ended in Mar. 2026 was 1.50%.
The historical rank and industry rank for PharmaCorp Rx's Net Margin % or its related term are showing as below:
TSXV:PCRX'
s Net Margin % Range Over the Past 10 Years
Min: -18.14 Med: -12.48 Max: -6.46
Current: -6.46
TSXV:PCRX's Net Margin % is ranked worse than 72.75% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 2.885
vs TSXV:PCRX: -6.46
PharmaCorp Rx (TSXV:PCRX) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
PharmaCorp Rx Net Margin % Related Terms
PharmaCorp Rx Net Margin % Historical Data
* Premium members only.
The historical data trend for PharmaCorp Rx's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, PharmaCorp Rx's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PharmaCorp Rx Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PharmaCorp Rx's Net Margin % distribution charts can be found below:
* The bar in red indicates where PharmaCorp Rx's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PharmaCorp Rx (TSXV:PCRX) has a Net Margin % of 1.50% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on PharmaCorp Rx and its competitors. According to the industry distribution chart, PharmaCorp Rx ranks #486 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 72.8%.
Is PharmaCorp Rx's Net Margin % too high?
PharmaCorp Rx's current Net Margin % is 1.50%. The Healthcare Providers & Services industry median Net Margin % is 2.89. PharmaCorp Rx's value of 1.50% is 48% below this industry median. Based on the distribution chart, PharmaCorp Rx ranks #486 out of 668 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, PharmaCorp Rx has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does PharmaCorp Rx's Net Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, PharmaCorp Rx ranks #486 out of 668 companies for Net Margin %. This places PharmaCorp Rx in the lower half of its industry. The industry median Net Margin % is 2.89. PharmaCorp Rx's value of 1.50% is 48% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.89, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PharmaCorp Rx's current Net Margin % of 1.50% is 48% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on PharmaCorp Rx and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PharmaCorp Rx's current Net Margin % is 1.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaCorp Rx stock overvalued right now?
PharmaCorp Rx (TSXV:PCRX) has a current Net Margin % of 1.50%. The current Net Margin % is 1.50% and 48% below the Healthcare Providers & Services industry median of 2.89. PharmaCorp Rx's overall GF Score™ is 36/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For PharmaCorp Rx (TSXV:PCRX), the current Net Margin % is 1.50% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PharmaCorp Rx Inc operates three PharmaChoice bannered pharmacies in Canada and will continue to acquire PharmaChoice Canada-branded pharmacies as it come to market in conjunction with its strategic alliance agreement with PharmaChoice Canada. The company will also acquire independently owned non-PharmaChoice Canada-bannered pharmacies in Canada, and thereafter, continue to operate such acquired pharmacies under a PharmaChoice Canada banner.
36GF Score
Get the complete analysis for TSXV:PCRX
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:PCRX has been successfully added to your 
